ロード中...
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
BACKGROUND: Traditional standard triple therapy for Helicobacter pylori (H. pylori) infection (proton pump inhibitor-clarithromycin-amoxicillin) can easily be converted to non-bismuth quadruple (concomitant) therapy by the addition of a nitroimidazole twice daily. AIM: To critically review evidence...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3308633/ https://ncbi.nlm.nih.gov/pubmed/22457599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S25419 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|